{"title":"接种 COVID-19 疫苗后的中毒性表皮坏死症:病例报告和文献综述。","authors":"Sachin Wali, Shreyas Gutte, Gaurav Pandey, Ajit Kumar, Mohan Gurjar, Jitendra Singh Chahar","doi":"10.6705/j.jacme.202406_14(2).0005","DOIUrl":null,"url":null,"abstract":"<p><p>Following vaccination for COVID-19, various cutaneous adverse reactions (CARs) are reported. Here is an Asian male in late 50's who developed necrotic skin with mucosal involvement 10 days following booster dose of ChAdOx1 nCov-19 vaccination. Based on disease course and morphology, toxic epidermal necrolysis (TEN) was suspected. The patient developed respiratory distress and was intubated, intravenous immunoglobulin (IVIG) administered at 2 g/kg body weight following which skin lesions healed in fourth week, the patient was discharged after 50 days of intensive care unit (ICU) stay. Severe CARs are rare following vaccination, of two components in ChAdOx1nCoV-19 adenoviral vector vaccine, virotopes cause T-cell mediated granulysin and granzyme B release leading to epidermal detachment and mucosal involvement of conducting airways causing respiratory failure. CARs can also occur in whom first and second dose was uneventful. Supportive therapy and prevention of sepsis are mainstay of management. Though the use of IVIG has shown conflicting results, our case was successfully managed with IVIG.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 2","pages":"94-97"},"PeriodicalIF":0.8000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11153313/pdf/","citationCount":"0","resultStr":"{\"title\":\"Toxic Epidermal Necrolysis After COVID-19 Vaccination: A Case Report and Review of Literature.\",\"authors\":\"Sachin Wali, Shreyas Gutte, Gaurav Pandey, Ajit Kumar, Mohan Gurjar, Jitendra Singh Chahar\",\"doi\":\"10.6705/j.jacme.202406_14(2).0005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Following vaccination for COVID-19, various cutaneous adverse reactions (CARs) are reported. Here is an Asian male in late 50's who developed necrotic skin with mucosal involvement 10 days following booster dose of ChAdOx1 nCov-19 vaccination. Based on disease course and morphology, toxic epidermal necrolysis (TEN) was suspected. The patient developed respiratory distress and was intubated, intravenous immunoglobulin (IVIG) administered at 2 g/kg body weight following which skin lesions healed in fourth week, the patient was discharged after 50 days of intensive care unit (ICU) stay. Severe CARs are rare following vaccination, of two components in ChAdOx1nCoV-19 adenoviral vector vaccine, virotopes cause T-cell mediated granulysin and granzyme B release leading to epidermal detachment and mucosal involvement of conducting airways causing respiratory failure. CARs can also occur in whom first and second dose was uneventful. Supportive therapy and prevention of sepsis are mainstay of management. Though the use of IVIG has shown conflicting results, our case was successfully managed with IVIG.</p>\",\"PeriodicalId\":14846,\"journal\":{\"name\":\"Journal of acute medicine\",\"volume\":\"14 2\",\"pages\":\"94-97\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11153313/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of acute medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.6705/j.jacme.202406_14(2).0005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"EMERGENCY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of acute medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6705/j.jacme.202406_14(2).0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
据报道,接种 COVID-19 疫苗后会出现各种皮肤不良反应 (CAR)。这里有一名年过五旬的亚洲男性,在接种 ChAdOx1 nCov-19 疫苗加强剂 10 天后出现皮肤坏死并伴有粘膜受累。根据病程和形态,怀疑是中毒性表皮坏死(TEN)。患者出现呼吸窘迫并被插管,静脉注射了每公斤体重 2 克的免疫球蛋白(IVIG),随后皮损在第四周愈合,患者在重症监护室(ICU)住了 50 天后出院。接种 ChAdOx1nCoV-19 腺病毒载体疫苗的两种成分后出现严重 CAR 的情况非常罕见,病毒载体会导致 T 细胞介导的粒细胞素和粒酶 B 释放,从而导致表皮脱落和呼吸道粘膜受累,引起呼吸衰竭。第一剂和第二剂均无不良反应的患者也可能发生 CAR。支持疗法和预防败血症是治疗的主要手段。虽然静脉注射免疫球蛋白(IVIG)的使用结果不尽相同,但我们的病例使用静脉注射免疫球蛋白(IVIG)获得了成功。
Toxic Epidermal Necrolysis After COVID-19 Vaccination: A Case Report and Review of Literature.
Following vaccination for COVID-19, various cutaneous adverse reactions (CARs) are reported. Here is an Asian male in late 50's who developed necrotic skin with mucosal involvement 10 days following booster dose of ChAdOx1 nCov-19 vaccination. Based on disease course and morphology, toxic epidermal necrolysis (TEN) was suspected. The patient developed respiratory distress and was intubated, intravenous immunoglobulin (IVIG) administered at 2 g/kg body weight following which skin lesions healed in fourth week, the patient was discharged after 50 days of intensive care unit (ICU) stay. Severe CARs are rare following vaccination, of two components in ChAdOx1nCoV-19 adenoviral vector vaccine, virotopes cause T-cell mediated granulysin and granzyme B release leading to epidermal detachment and mucosal involvement of conducting airways causing respiratory failure. CARs can also occur in whom first and second dose was uneventful. Supportive therapy and prevention of sepsis are mainstay of management. Though the use of IVIG has shown conflicting results, our case was successfully managed with IVIG.